BC Week In Review | May 3, 2010
Clinical News

Aspirin-PC: Phase II data

In a U.S. Phase II trial in 201 healthy adults ages 50-75, daily PL2200 for 7 days significantly reduced the incidence of gastric and duodenal ulcers by 71% (p=0.0069) and the incidence of combined erosions...
BC Week In Review | Feb 25, 2008
Clinical News

Aspirin-PC: Phase I started

PLx began a single-dose, crossover Phase I trial to compare 325 mg and 650 mg of oral PL 2200 Aspirin-PC vs. generic aspirin in about 32 healthy volunteers. PLx Pharma Inc. , Houston, Texas   Product:...
Items per page:
1 - 2 of 2